Posts

ETX101 shows promising early signals in Dravet syndrome

on

Sanofi rules out major restructuring as it prepares for Dupixent’s patent loss

on

FDA approves camizestrant combination for ESR1-mutated advanced breast cancer

on

Recent Alzheimer’s developments across France, Germany, Italy and Spain

on

Actio’s remaining drug pipeline moves to Setara after Jazz buyout

on

Lilly raises 2026 outlook as GLP-1 demand and Medicare Bridge access boost sales

on

AstraZeneca targets $1.5B in annual savings to reinvest in its pipeline

on

Sanofi weighs selective “moonshot” deals as it plans for the Dupixent patent cliff

on

Dren Bio raises $350 million to advance rare blood cancer drug

on

Flagship combines three biotech platforms to launch AI drug-discovery company Etcelera

on

Aspen raises $141M and Bambusa brings in $169M in biotech IPOs

on

FDA draft proposes a streamlined route for some patient-specific gene-editing therapies

on

Oura and UC San Diego Health launch smart-ring study of obesity treatment outcomes

on